Retatrutide is an innovative peptide with significant applications in advanced metabolic research. This triple-action compound targets GLP-1, GIP, and glucagon receptors, making it a cutting-edge focus for studying complex metabolic processes.

Key Features:
• Triple Receptor Agonist – Simultaneously activates GLP-1, GIP, and glucagon receptors
• Metabolic Insight – Explores mechanisms related to glucose regulation, lipid metabolism, and energy balance
• Research Only – For qualified professionals investigating advanced peptide pathways